List of Publications

Vanessa M. Beutgen

Ordered by date

  1. Secretome Analysis Using Affinity Proteomics and Immunoassays: A Focus on Tumor Biology.
    Beutgen, V.M., Shinkevich, V., Pörschke, J., Meena, C., Steitz, A.M., Pogge von Strandmann, E., Graumann, J., and Gómez-Serrano, M.
    Molecular & Cellular Proteomics
    2024. 23(9), 100830
    DOI: 10.1016/j.mcpro.2024.100830

  2. BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells.
    Alashkar Alhamwe, B., Ponath, V., Alhamdan, F., Dörsam, B., Landwehr, C., Linder, M., Pauck, K., Miethe, S., Garn, H., Finkernagel, F., Brichkina, A., Lauth, M., Tiwari, D.K., Buchholz, M., Bachurski, D., Elmshäuser, S., Nist, A., Stiewe, T., Pogge von Strandmann, L., Szymański, W., Beutgen, V., Graumann, J., Teply-Szymanski, J., Keber, C., Denkert, C., Jacob, R., Preußer, C., and Pogge von Strandmann, E.
    Cellular & Molecular Immunology
    2024. 21(8), 918-931
    DOI: 10.1038/s41423-024-01195-1

  3. Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates.
    Beutgen, V.M., Bhagwat, A.M., Steitz, A.M., Reinartz, S., Müller, R., and Graumann, J.
    Analytical Chemistry
    2024. 96(23), 9332-9342
    DOI: 10.1021/acs.analchem.3c04116

  4. Advances in aqueous humor proteomics for biomarker discovery and disease mechanisms exploration: a spotlight on primary open angle glaucoma.
    Beutgen, V.M., and Graumann, J.
    Frontiers in Molecular Neuroscience
    2024. 17
    DOI: 10.3389/fnmol.2024.1397461

  5. Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells.
    Neuhaus, F., Lieber, S., Shinkevich, V., Steitz, A.M., Raifer, H., Roth, K., Finkernagel, F., Worzfeld, T., Burchert, A., Keber, C., Nist, A., Stiewe, T., Reinartz, S., Beutgen, V.M., Graumann, J., Pauck, K., Garn, H., Gaida, M., Müller, R., and Huber, M.
    Clinical and Translational Medicine
    2024. 14(4), e1604
    DOI: 10.1002/ctm2.1604

  6. TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion.
    Steitz, A.M., Schröder, C., Knuth, I., Keber, C.U., Sommerfeld, L., Finkernagel, F., Jansen, J.M., Wagner, U., Müller-Brüsselbach, S., Worzfeld, T., Huber, M., Beutgen, V.M., Graumann, J., Pogge Von Strandmann, E., Müller, R., and Reinartz, S.
    iScience
    2023. 26(12), 108401
    DOI: 10.1016/j.isci.2023.108401

  7. Association of autoantibody levels with different stages of age-related macular degeneration (AMD): Results from the population-based Gutenberg Health Study (GHS).
    Korb, C.A., Lackner, K.J., Wolters, D., Schuster, A.K., Nickels, S., Beutgen, V.M., Münzel, T., Wild, P.S., Beutel, M.E., Schmidtmann, I., Pfeiffer, N., and Grus, F.H.
    Graefe’s Archive for Clinical and Experimental Ophthalmology
    2023. 261(10), 2763-2773
    DOI: 10.1007/s00417-023-06085-2

  8. Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1.
    Fomo, K.N., Schmelter, C., Atta, J., Beutgen, V.M., Schwarz, R., Perumal, N., Govind, G., Speck, T., Pfeiffer, N., and Grus, F.H.
    Frontiers in Medicine
    2022. 9, 993351
    DOI: 10.3389/fmed.2022.993351

  9. A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma.
    Tonner, H., Hunn, S., Auler, N., Schmelter, C., Beutgen, V.M., von Pein, H.D., Pfeiffer, N., and Grus, F.H.
    International Journal of Molecular Sciences
    2022. 23(8), 4107
    DOI: 10.3390/ijms23084107

  10. Contribution of the Commensal Microflora to the Immunological Homeostasis and the Importance of Immune-Related Drug Development for Clinical Applications.
    Beutgen, V.M., Schmelter, C., Pfeiffer, N., and Grus, F.H.
    International Journal of Molecular Sciences
    2021. 22(16), 8896
    DOI: 10.3390/ijms22168896

  11. Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.
    Beutgen, V.M., Pfeiffer, N., and Grus, F.H.
    Frontiers in Immunology
    2021. 12, 616421
    DOI: 10.3389/fimmu.2021.616421

  12. Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients.
    Bell, K., Beutgen, V.M., Nickels, S., Lorenz, K., Scheller, Y., Elbaz, H., Peto, T., Ponto, K.A., Schulz, A., Wild, P.S., Münzel, T., Lackner, K.J., Schmidtmann, I., Beutel, M., Pfeiffer, N., Grus, F.H., and Schuster, A.K.
    Journal of Ophthalmology
    2020. 2020, 8386160
    DOI: 10.1155/2020/8386160

  13. Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire.
    Beutgen, V.M., Schmelter, C., Pfeiffer, N., and Grus, F.H.
    Clinical & Translational Immunology
    2020. 9(3), e01101
    DOI: 10.1002/cti2.1101

  14. An In-Depth View of the Porcine Trabecular Meshwork Proteome.
    Funke, S., Beutgen, V.M., Bechter, L., Schmelter, C., Zurawski, V., Perumal, N., Pfeiffer, N., and Grus, F.H.
    International Journal of Molecular Sciences
    2019. 20(10), E2526
    DOI: 10.3390/ijms20102526

  15. Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA).
    Beutgen, V.M., Perumal, N., Pfeiffer, N., and Grus, F.H.
    Frontiers in Immunology
    2019. 10, 381
    DOI: 10.3389/fimmu.2019.00381